Prevention of restenosis by lovastatin after successful coronary angioplasty
- 30 June 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (6), 1600-1608
- https://doi.org/10.1016/0002-8703(91)90002-y
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Effect of antiplatelet therapy on restenosis after experimental angioplastyThe American Journal of Cardiology, 1984
- Relative cost of coronary angioplasty and bypass surgery in a one-vessel disease modelThe American Journal of Cardiology, 1984
- Early and late morphologic changes in major epicardial coronary arteries after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1984
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984